Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: Study design and rationale

This publication has 61 references indexed in Scilit:

• A randomized, placebo-controlled trial of early eptifibatide for non-ST–segment elevation acute coronary syndromes
  American Heart Journal, 2003
• Combining enoxaparin and glycoprotein IIb/IIIa antagonists for the treatment of acute coronary syndromes: final results of the National Investigators Collaborating on Enoxaparin-3 (NICE-3) study11Guest Editor for this manuscript was David A. Vorchheimer, MD, Mount Sinai Medical Center, New York, NY.
  American Heart Journal, 2003
• Relationship of Activated Partial Thromboplastin Time to Coronary Events and Bleeding in Patients With Acute Coronary Syndromes Who Receive Heparin
  Circulation, 2003
• Low–molecular-weight heparin therapy for non-ST-elevation acute coronary syndromes and during percutaneous coronary intervention: An expert consensus*
  American Heart Journal, 2002
• Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial
  Published by Elsevier ,2002
• ACC/AHA guidelines for the management of patients with unstable angina and non–st-segment elevation myocardial infarction: A report of the american college of cardiology/ american heart association task force on practice guidelines (committee on the management of patients with unstable angina)
  Published by Elsevier ,2000
• A randomized comparison of bivalirudin and heparin in patients undergoing coronary angioplasty for postinfarction angina
  The American Journal of Cardiology, 1998
• Therapeutic Concentrations of Heparin Augment Platelet Activation at the Time of Coronary Angiography
  Journal of Cardiovascular Pharmacology and Therapeutics, 1998
• Hirulog
  Coronary Artery Disease, 1996
• The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
  New England Journal of Medicine, 1992